Post-approval studies (Phase 4)UnknownNCT02693470
What this trial is testing
The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)
Who this might be right for
Psoriasis With Cell-derived Microparticles
Chang Gung Memorial Hospital 100